We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

25 hedge funds and large institutions have $12M invested in VolitionRx Ltd in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

7% more capital invested

Capital invested by funds: $11.2M → $12M (+$765K)

0.12% more ownership

Funds ownership: 0.97% → 1.09% (+0.12%)

7% less funds holding

Funds holding: 27 → 25 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$1.56M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$41.4K
3
Squarepoint
Squarepoint
New York
+$36.2K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$18.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.8K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$164K
2
Citadel Advisors
Citadel Advisors
Florida
-$40.9K
3
Millennium Management
Millennium Management
New York
-$29.7K
4
TSS
Two Sigma Securities
New York
-$16.4K
5
UBS Group
UBS Group
Switzerland
-$14.4K

VNRX Hedge Fund Activity: Q1 2025 in Review

25 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2025, worth a combined $12M — up 6.8% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VNRX and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Lagoda Investment Management, adding an estimated $1.56M. The largest seller was Armistice Capital, cutting an estimated $164K.

  • 25 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2025, down from 27 in Q4 2024.
  • Funds reported $12M of VolitionRx Ltd stock for Q1 2025, up 6.8% quarter-over-quarter.
  • 4 funds opened new VolitionRx Ltd positions in Q1 2025 and 6 closed out, a net change of -2 holders.
  • The largest VolitionRx Ltd buyer in Q1 2025 was Lagoda Investment Management, an estimated $1.56M added.
  • The largest VolitionRx Ltd seller in Q1 2025 was Armistice Capital, an estimated $164K sold.

Based on aggregated 13F filings for Q1 2025.